BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23900839)

  • 1. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
    Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
    J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.
    Spinks D; Shanks EJ; Cleghorn LA; McElroy S; Jones D; James D; Fairlamb AH; Frearson JA; Wyatt PG; Gilbert IH
    ChemMedChem; 2009 Dec; 4(12):2060-9. PubMed ID: 19924760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.
    Patterson S; Alphey MS; Jones DC; Shanks EJ; Street IP; Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
    J Med Chem; 2011 Oct; 54(19):6514-30. PubMed ID: 21851087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.
    Richardson JL; Nett IR; Jones DC; Abdille MH; Gilbert IH; Fairlamb AH
    ChemMedChem; 2009 Aug; 4(8):1333-40. PubMed ID: 19557801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress.
    Krieger S; Schwarz W; Ariyanayagam MR; Fairlamb AH; Krauth-Siegel RL; Clayton C
    Mol Microbiol; 2000 Feb; 35(3):542-52. PubMed ID: 10672177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.
    Jones DC; Ariza A; Chow WH; Oza SL; Fairlamb AH
    Mol Biochem Parasitol; 2010 Jan; 169(1):12-9. PubMed ID: 19747949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
    Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
    Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase.
    Patterson S; Jones DC; Shanks EJ; Frearson JA; Gilbert IH; Wyatt PG; Fairlamb AH
    ChemMedChem; 2009 Aug; 4(8):1341-53. PubMed ID: 19557802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do the alkaloids emetine and homoharringtonine kill trypanosomes? An insight into their molecular modes of action.
    Krstin S; Mohamed T; Wang X; Wink M
    Phytomedicine; 2016 Dec; 23(14):1771-1777. PubMed ID: 27912879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
    Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
    ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary targets of the sesquiterpene lactone deoxymikanolide on Trypanosoma cruzi.
    Puente V; Laurella LC; Spina RM; Lozano E; Martino VS; Sosa MA; Sülsen VP; Lombardo E
    Phytomedicine; 2019 Mar; 56():27-34. PubMed ID: 30668348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods.
    Wyllie S; Oza SL; Patterson S; Spinks D; Thompson S; Fairlamb AH
    Mol Microbiol; 2009 Nov; 74(3):529-40. PubMed ID: 19558432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
    Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.